• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study.

作者信息

Ma Jia, Yin Jing, Qian Yu, Wu Yuan

机构信息

Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430071, PR China.

Department of Respiratory Disease and Intensive Care, Renmin Hospital of Wuhan University, Wuhan 430060, PR China.

出版信息

J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.04.006. Epub 2020 Apr 14.

DOI:10.1016/j.jinf.2020.04.006
PMID:32298677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7194544/
Abstract
摘要

相似文献

1
Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study.新型冠状病毒肺炎癌症患者的临床特征与预后：一项单中心回顾性研究
J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.04.006. Epub 2020 Apr 14.
2
Poor clinical outcomes for patients with cancer during the COVID-19 pandemic.在新冠疫情期间癌症患者的临床预后较差。
Lancet Oncol. 2020 Jul;21(7):862-864. doi: 10.1016/S1470-2045(20)30311-9. Epub 2020 May 29.
3
Cancer in intensive care unit patients with COVID-19.新冠肺炎重症监护病房患者中的癌症
J Infect. 2020 Aug;81(2):e124-e125. doi: 10.1016/j.jinf.2020.05.053. Epub 2020 May 28.
4
Risk factors for in-hospital mortality in patients with cancer and COVID-19.癌症合并新型冠状病毒肺炎患者院内死亡的危险因素
Lancet Oncol. 2020 Sep;21(9):e407. doi: 10.1016/S1470-2045(20)30390-9.
5
Risk factors for in-hospital mortality in patients with cancer and COVID-19.癌症合并新型冠状病毒肺炎患者院内死亡的危险因素
Lancet Oncol. 2020 Sep;21(9):e406. doi: 10.1016/S1470-2045(20)30426-5.
6
Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series.中国危重症新冠肺炎患者使用体外膜肺氧合（ECMO）治疗的预后：一项回顾性病例系列研究。
Crit Care. 2020 Apr 15;24(1):148. doi: 10.1186/s13054-020-2840-8.
7
Risk factors for in-hospital mortality in patients with cancer and COVID-19 - Authors' reply.癌症合并新型冠状病毒肺炎患者院内死亡的危险因素——作者回复
Lancet Oncol. 2020 Sep;21(9):e408. doi: 10.1016/S1470-2045(20)30467-8.
8
Management of hepatocellular carcinoma in the time of COVID-19.2019冠状病毒病时期肝细胞癌的管理
Ann Oncol. 2020 Aug;31(8):1084-1085. doi: 10.1016/j.annonc.2020.04.007. Epub 2020 Apr 21.
9
Clinical Characteristics of Covid-19 in China.中国新冠肺炎的临床特征
N Engl J Med. 2020 May 7;382(19):1859. doi: 10.1056/NEJMc2005203. Epub 2020 Mar 27.
10
Clinical Characteristics of Covid-19 in China.中国新冠肺炎的临床特征
N Engl J Med. 2020 May 7;382(19):1860. doi: 10.1056/NEJMc2005203. Epub 2020 Mar 27.

引用本文的文献

1
Impact of COVID-19 vaccination on cancer patients: safety, efficacy, and long-term effects.2019冠状病毒病疫苗接种对癌症患者的影响：安全性、有效性及长期影响
Support Care Cancer. 2025 Aug 4;33(8):753. doi: 10.1007/s00520-025-09783-1.
2
Association of Cancer History with COVID-19 Risk and Outcomes among Older Postmenopausal Women: Results from the Women's Health Initiative.绝经后老年女性癌症病史与 COVID-19 风险及预后的关联：妇女健康倡议的结果
Cancer Epidemiol Biomarkers Prev. 2025 Aug 1;34(8):1286-1294. doi: 10.1158/1055-9965.EPI-24-1682.
3
Sociodemographic, medical, health behavior, and psychosocial factors associated with COVID-19 diagnoses in the New Jersey cancer survivor cohort.新泽西州癌症幸存者队列中与新冠病毒疾病（COVID-19）诊断相关的社会人口学、医学、健康行为和心理社会因素。
Cancer Causes Control. 2025 Apr 25. doi: 10.1007/s10552-025-01997-2.
4
Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19.阿兹夫定与奈玛特韦/利托那韦治疗新冠病毒肺炎癌症患者的疗效和安全性比较
Sci Rep. 2025 Mar 31;15(1):11022. doi: 10.1038/s41598-025-85677-w.
5
Prognostic Factors for Survival or Severity After COVID-19 Infection in Cancer Patients: A Systematic Review and Meta-Analysis.癌症患者感染新型冠状病毒肺炎后的生存或严重程度的预后因素：一项系统评价和荟萃分析
J Rhinol. 2023 Jul;30(2):69-79. doi: 10.18787/jr.2023.00015. Epub 2023 Jul 28.
6
IGSF1: a biomarker for predicting prognosis, immunotherapy response, and drug candidates in COVID-19 combined hepatocellular carcinoma.IGSF1：一种用于预测COVID-19合并肝细胞癌预后、免疫治疗反应及候选药物的生物标志物。
Discov Oncol. 2024 Oct 29;15(1):599. doi: 10.1007/s12672-024-01483-2.
7
COVID-19 and Cancer: A Comparison of the Two Important Pandemic Waves in an Indian Cancer Patients' Cohort.2019冠状病毒病与癌症：印度癌症患者队列中两次重要疫情浪潮的比较
South Asian J Cancer. 2023 Aug 24;13(1):57-62. doi: 10.1055/s-0043-1772702. eCollection 2024 Jan.
8
Early predictors of intensive care unit admission among COVID-19 patients in Qatar.卡塔尔 COVID-19 患者入住重症监护病房的早期预测指标。
Front Public Health. 2024 Mar 20;12:1278046. doi: 10.3389/fpubh.2024.1278046. eCollection 2024.
9
COVID-19 and Cancer: Questions to Be Answered.新冠病毒与癌症：待解答的问题
J Hosp Palliat Care. 2021 Mar 1;24(1):66-68. doi: 10.14475/jhpc.2021.24.1.66.
10
Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.鉴定调控肝癌肿瘤免疫微环境和预后的 COVID-19 关键基因。
Funct Integr Genomics. 2023 Aug 4;23(3):262. doi: 10.1007/s10142-023-01184-z.

本文引用的文献

1
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.COVID-19 感染癌症患者的临床特征：中国武汉三家医院的回顾性病例研究。
Ann Oncol. 2020 Jul;31(7):894-901. doi: 10.1016/j.annonc.2020.03.296. Epub 2020 Mar 26.
2
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.SARS-CoV-2 在武汉一家三级医院癌症患者中的传播。
JAMA Oncol. 2020 Jul 1;6(7):1108-1110. doi: 10.1001/jamaoncol.2020.0980.
3
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
4
Clinical progression of patients with COVID-19 in Shanghai, China.中国上海 COVID-19 患者的临床进展。
J Infect. 2020 May;80(5):e1-e6. doi: 10.1016/j.jinf.2020.03.004. Epub 2020 Mar 19.
5
Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、淋巴细胞与单核细胞比值和预后营养指数对 T1-2 期直肠癌临床结局的预测意义。
BMC Cancer. 2020 Mar 12;20(1):208. doi: 10.1186/s12885-020-6698-6.
6
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.